Center Laboratories (4123.TWO) Stock Price

Center Laboratories Price

CLOSED
37.70TWD-0.40 (-1.06 %)
Market closed

Revenue has compounded at 9.9% per year over the past 19 years to 1.52 B TWD. Earnings per share have grown at 45.2% per year over the last 11 years. Center Laboratories's net margin stands at 614.9%, up from 363.2% several years earlier. Center Laboratories currently offers a dividend yield of about 1.92%. The stock trades about 12% above its 52-week low.

Center Laboratories stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Center Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Center Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Center Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Center Laboratories Stock Price History
DateCenter Laboratories Price
7/29/202637.70 TWD
7/28/202638.10 TWD
7/27/202638.40 TWD
7/24/202638.25 TWD
7/23/202638.30 TWD
7/22/202638.35 TWD
7/21/202638.05 TWD
7/20/202637.10 TWD
7/17/202637.00 TWD
7/16/202638.00 TWD
7/15/202638.05 TWD
7/14/202637.40 TWD
7/13/202638.25 TWD
7/10/202638.95 TWD
7/9/202638.95 TWD
7/8/202639.35 TWD
7/7/202639.50 TWD
7/6/202639.80 TWD
7/3/202639.65 TWD
7/2/202638.40 TWD
7/1/202638.10 TWD
6/30/202638.15 TWD
6/29/202637.95 TWD
6/26/202637.20 TWD
6/25/202637.85 TWD
6/24/202638.25 TWD
6/23/202637.30 TWD
6/22/202637.00 TWD
6/18/202637.10 TWD
6/17/202637.20 TWD
6/16/202637.20 TWD
6/15/202637.65 TWD
6/12/202637.70 TWD
6/11/202637.35 TWD
6/10/202637.95 TWD
6/9/202637.80 TWD
6/8/202637.90 TWD
6/5/202638.80 TWD
6/4/202638.45 TWD
6/3/202638.35 TWD
6/2/202638.35 TWD
5/29/202637.90 TWD
5/28/202637.80 TWD
5/27/202637.25 TWD
5/26/202637.70 TWD
5/25/202637.90 TWD
5/22/202638.70 TWD
5/21/202638.75 TWD
5/20/202638.20 TWD
5/19/202637.95 TWD
5/14/202639.45 TWD
4/2/202641.70 TWD
4/1/202642.00 TWD
3/31/202640.50 TWD
3/30/202640.50 TWD
3/27/202640.80 TWD
3/26/202641.40 TWD
3/25/202641.65 TWD
3/24/202641.85 TWD
3/23/202641.10 TWD
3/20/202642.25 TWD
3/19/202642.80 TWD
3/18/202644.35 TWD
3/17/202644.65 TWD
3/16/202644.40 TWD
3/13/202643.75 TWD
3/12/202644.65 TWD
3/11/202644.40 TWD
3/10/202643.85 TWD
3/9/202644.55 TWD
3/6/202648.95 TWD
3/5/202648.00 TWD
3/4/202649.35 TWD
3/3/202644.90 TWD
3/2/202645.00 TWD
2/26/202643.80 TWD
2/25/202643.15 TWD
2/24/202643.65 TWD
2/23/202642.40 TWD
2/11/202640.00 TWD
2/10/202639.70 TWD
2/9/202639.05 TWD
2/6/202639.40 TWD
2/5/202639.60 TWD
2/4/202640.10 TWD
2/3/202639.45 TWD
2/2/202639.75 TWD
1/30/202640.30 TWD
1/29/202641.40 TWD
1/28/202642.45 TWD
1/27/202643.30 TWD
1/26/202642.50 TWD
1/23/202642.30 TWD
1/22/202641.50 TWD
1/21/202641.00 TWD
1/20/202641.70 TWD
1/19/202641.65 TWD
1/16/202642.20 TWD
1/15/202641.80 TWD
1/14/202641.20 TWD
1/13/202640.60 TWD
1/12/202640.95 TWD
1/9/202640.90 TWD
1/8/202640.25 TWD
1/7/202639.40 TWD
1/6/202640.15 TWD
1/5/202640.45 TWD
1/2/202640.50 TWD
12/31/202541.60 TWD
12/30/202541.45 TWD
12/29/202539.20 TWD
12/26/202537.10 TWD
12/24/202537.05 TWD
12/23/202537.05 TWD
12/22/202537.65 TWD
12/19/202538.00 TWD
12/18/202537.80 TWD
12/17/202537.55 TWD
12/16/202537.60 TWD
12/15/202537.60 TWD
12/12/202537.45 TWD
12/11/202537.05 TWD
12/10/202536.65 TWD
12/9/202537.25 TWD
12/8/202536.90 TWD
12/5/202537.65 TWD
12/4/202537.55 TWD
12/3/202537.35 TWD
12/2/202538.35 TWD
12/1/202538.20 TWD
11/28/202537.95 TWD
11/27/202536.60 TWD
11/26/202536.50 TWD
11/25/202536.10 TWD
11/24/202536.65 TWD
11/21/202535.90 TWD
11/20/202536.35 TWD
11/19/202535.65 TWD
11/18/202536.05 TWD
11/17/202536.95 TWD
11/14/202537.65 TWD
11/13/202537.00 TWD
11/12/202536.75 TWD
11/11/202535.15 TWD
11/10/202535.10 TWD
11/7/202534.60 TWD
11/6/202535.20 TWD
11/5/202535.55 TWD
11/4/202536.85 TWD
11/3/202535.30 TWD
10/31/202533.95 TWD
10/30/202533.80 TWD
10/29/202534.05 TWD
10/28/202533.75 TWD
10/27/202534.30 TWD
10/23/202534.50 TWD
10/22/202534.55 TWD
10/21/202534.75 TWD
10/20/202533.60 TWD
10/17/202533.85 TWD
10/16/202533.80 TWD
10/15/202533.75 TWD
10/14/202533.90 TWD
10/13/202534.15 TWD
10/9/202534.60 TWD
10/8/202534.80 TWD
10/7/202535.10 TWD
10/3/202535.70 TWD
10/2/202536.64 TWD
10/1/202536.83 TWD
9/30/202536.98 TWD
9/29/202536.98 TWD
9/26/202536.98 TWD
9/25/202537.21 TWD
9/24/202537.40 TWD
9/23/202537.40 TWD
9/22/202537.31 TWD
9/19/202537.59 TWD
9/18/202537.26 TWD
9/17/202536.98 TWD
9/16/202537.07 TWD
9/15/202536.50 TWD
9/12/202536.55 TWD
9/11/202536.83 TWD
9/10/202537.78 TWD
9/9/202538.02 TWD
9/8/202538.02 TWD
9/5/202538.36 TWD
9/4/202538.40 TWD
9/3/202539.59 TWD
9/2/202538.26 TWD
9/1/202535.79 TWD
8/29/202535.41 TWD
8/28/202535.60 TWD
8/27/202535.50 TWD
8/26/202535.83 TWD
8/25/202536.12 TWD
8/22/202536.98 TWD
8/21/202535.79 TWD
8/20/202534.79 TWD
8/19/202535.41 TWD
8/18/202535.41 TWD
8/15/202535.79 TWD
8/14/202535.88 TWD
8/13/202535.31 TWD
8/12/202535.55 TWD
8/11/202535.26 TWD
8/8/202536.12 TWD
8/7/202536.36 TWD
8/6/202536.88 TWD
8/5/202536.93 TWD
8/4/202536.40 TWD
Access this data via the Eulerpool API
Get Free API Key

Center Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
21.65 B TWD
1.39 B TWD
6.08 B TWD
Jan 1, 2019
1.44 B TWD
198.17 M TWD
-203.59 M TWD
Jan 1, 2020
717.05 M TWD
372.69 M TWD
3.79 B TWD
Jan 1, 2021
500.11 M TWD
1.05 B TWD
1.82 B TWD
Jan 1, 2022
767.72 M TWD
131.94 M TWD
-575.62 M TWD
Jan 1, 2023
1.39 B TWD
-79.27 M TWD
-1.05 B TWD
Jan 1, 2024
1.62 B TWD
234.32 M TWD
-1.10 B TWD
Jan 1, 2025
1.52 B TWD
0.00 TWD
9.32 B TWD

Center Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 1, 2026, 1:19 PM
 
REVENUEB TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB TWD
EBITB TWD
EBIT MARGIN%
NET INCOMEB TWD
NET INCOME GROWTH%
DIV.TWD
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
0.570.680.710.740.906.7915.0419.3921.651.440.720.500.771.391.621.52
23.1620.214.243.9321.19656.35121.4228.9411.64-93.36-50.10-30.2653.4081.7516.00-6.25
41.6539.4740.5337.1139.9835.5141.5743.5847.7243.0848.8151.8052.9344.3346.2640.96
0.240.270.290.280.362.416.258.4510.330.620.350.260.410.620.750.62
-0.02–-0.04-0.04-0.07-0.050.430.891.390.200.371.050.13-0.080.23–
-3.870.58-5.61-5.26-7.68-0.682.854.586.4013.7851.88209.8017.08-5.6714.47–
0.010.040.100.050.330.420.020.256.08-0.203.791.82-0.58-1.05-1.109.32
-91.30250.00135.71-48.48552.9426.43-95.491,210.532,342.97-103.34-1,965.02-52.03-131.6682.095.35-945.15
––––––––––––2.120.901.430.72
–––––––––––––-57.5558.89-49.65
260.80260.80339.30350.26389.64394.68514.87507.73520.65565.96573.48605.65653.74686.06699.62699.62
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Center Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Center Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Center Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Center Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Center Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Center Laboratories stock margins

The Center Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Center Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Center Laboratories.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
47.72 %
6.40 %
28.10 %
Jan 1, 2019
43.11 %
13.78 %
-14.16 %
Jan 1, 2020
48.85 %
51.98 %
528.07 %
Jan 1, 2021
51.92 %
209.89 %
363.16 %
Jan 1, 2022
52.92 %
17.19 %
-74.98 %
Jan 1, 2023
44.34 %
-5.69 %
-75.15 %
Jan 1, 2024
46.29 %
14.48 %
-68.22 %
Jan 1, 2025
40.97 %
0.00 %
614.89 %

Center Laboratories Stock Revenue, EBIT, Earnings per Share

The Center Laboratories earnings per share therefore indicates how much revenue Center Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
41.58 TWD
2.66 TWD
11.68 TWD
Jan 1, 2019
2.54 TWD
0.35 TWD
-0.36 TWD
Jan 1, 2020
1.25 TWD
0.65 TWD
6.60 TWD
Jan 1, 2021
0.83 TWD
1.73 TWD
3.00 TWD
Jan 1, 2022
1.17 TWD
0.20 TWD
-0.88 TWD
Jan 1, 2023
2.03 TWD
-0.12 TWD
-1.53 TWD
Jan 1, 2024
2.31 TWD
0.33 TWD
-1.58 TWD
Jan 1, 2025
0.00 TWD
0.00 TWD
0.00 TWD

Center Laboratories business model & stock analysis

Center Laboratories Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Center Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

Center Laboratories annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Center Laboratories shares outstanding

The number of shares of Center Laboratories was 699.62 M in 2025. This indicates how many shares Center Laboratories is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
520.65 M Stocks
Jan 1, 2019
565.96 M Stocks
Jan 1, 2020
573.48 M Stocks
Jan 1, 2021
605.65 M Stocks
Jan 1, 2022
653.74 M Stocks
Jan 1, 2023
686.06 M Stocks
Jan 1, 2024
699.62 M Stocks
Jan 1, 2025
699.62 M Stocks

Center Laboratories stock splits

In Center Laboratories's history, there have been no stock splits.

Center Laboratories Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.72TWD↓ 49.4%1×
Oct 3, 20250.72TWD↓ 49.4%1/1
20241.43TWD↑ 58.6%1×
20230.90TWD↓ 57.5%1×
20222.12TWD—1×

Center Laboratories dividend history and estimates

In 2025, Center Laboratories paid a dividend amounting to 0.72 TWD. Dividend means that Center Laboratories distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
2.12 TWD
0.00 TWD
Jan 1, 2023
0.90 TWD
0.00 TWD
Jan 1, 2024
1.43 TWD
0.00 TWD
Jan 1, 2025
0.72 TWD
0.00 TWD

Center Laboratories dividend payout ratio

In 2025, Center Laboratories had a payout ratio of 0.00%. The payout ratio indicates the percentage of the company's profits that Center Laboratories distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
0.00 %
Jan 1, 2019
0.00 %
Jan 1, 2020
0.00 %
Jan 1, 2021
0.00 %
Jan 1, 2022
-238.71 %
Jan 1, 2023
-61.81 %
Jan 1, 2024
-86.31 %
Jan 1, 2025
0.00 %
Price targets and forecasts for Center Laboratories are not yet available.

Center Laboratories shareholder structure

% Name
8.87105%
Li Jung Technology
Li Jung Technology
5.56282%
O Shih Foods Company Ltd.
O Shih Foods Company Ltd.
3.40879%
Jason Technology Co., Ltd.
Jason Technology Co., Ltd.
2.63540%
DeFu Ore Investment Fund
DeFu Ore Investment Fund
2.23603%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.43817%
Far Glory Life Insurance Company Ltd.
Far Glory Life Insurance Company Ltd.

Center Laboratories Beneficial Ownership Filings (SEC 13D/G)

Free Float
78.5%
Float Shares
-
Shares Outstanding
-

Center Laboratories Executives and Management Board

JH

Mr. Jui-Pao Hsu

General Manager

Compensation2.61 M TWD
SW

Ms. Su-Chi Wang

Chairman of the Board, Chief Operating Officer, Chief Investment Officer · since 2000

AM

Ms. An-Ni Mao

Manager of Finance & Accounting

CL

Ms. Chiun-Yu Lin

Plant Manager

QT

Qingyu Tang

Corporate Governance Officer

Frequently asked questions about Center Laboratories

Converted at the current exchange rate, the Center Laboratories share trades at 1.01 EUR (37.70 TWD).

All fundamentals and in-depth analysis of Center Laboratories

Our stock analysis for Center Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Center Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Center Laboratories Stock
Center Laboratories Revenue→
Center Laboratories Stock
Center Laboratories Net Income→
Center Laboratories Stock
Center Laboratories P/E→
Center Laboratories Stock
Center Laboratories P/S→
Center Laboratories Stock
Center Laboratories EBIT→
Center Laboratories Stock
Center Laboratories Dividend→
Center Laboratories Stock
Center Laboratories Directors Dealings→
Center Laboratories Stock
Center Laboratories Stocks→
Center Laboratories Stock
Center Laboratories Market capitalization→
Center Laboratories Stock
Center Laboratories Debt→
Center Laboratories Stock
Center Laboratories Liabilities→
Center Laboratories Stock
Center Laboratories Equity→
Center Laboratories Stock
Center Laboratories AAQS→
Center Laboratories Stock
Center Laboratories Employees→
Center Laboratories Stock
Center Laboratories ROE→
Center Laboratories Stock
Center Laboratories ROA→
Center Laboratories Stock
Center Laboratories ROCE→
Center Laboratories Stock
Center Laboratories News→
Center Laboratories Stock
Center Laboratories Analyst Price Targets→

Health Stocks

Centrum Medyczne Enel MedCentenial Surgical SutureCentury TherapeuticsCenteneCeribellCenraCertaraCelyad OncologyCerusCelularityCervoMedCelon PharmaAll Stocks A–Z →